Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA and 68Ga-RM2 PET/MRI for Staging Prostate Cancer
NCT06484361Phase 2Recruiting
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2020
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Diagnostic accuracy of PET/MRI with 68Ga-PSMA and 68Ga-RM2 for localization of primary prostate cancer. Started Sep 2020; status: recruiting.
Beyond the preview
Go deeper on NCT06484361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06484361.